Oteseconazole

奥特康唑

Report date: 2024/12/06 11:03:11
NMEQIDP

Base Information

Drug NameOteseconazole
Drug Alias NameVivjoa瑞必康SHR-8008VT-1161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 51 inhibitors
TargetsCytochrome P450 51
Therapy Area/IndicationsVulvovaginitisTinea PedisOnychomycosis +[7] 
Global Approved IndicationsCandidiasis, Vulvovaginal
Approved Indications in ChinaCandidiasis, Vulvovaginal
Original Approved Country/TerritoryUnited States
Original Approved Date2022/04/26
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesViamet Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesEvenus Pharmaceutical Laboratories IncGedeon RichterMycovia Pharmaceuticals Inc +[5] 
Inactive CompaniesViamet
Active IndicationsVulvovaginitisCandidiasis, VulvovaginalMycoses
Inactive IndicationsTinea PedisOnychomycosisVaginosis, Bacterial +[4] 

Other Information

ATC CodeG01AF
Related LinksWikipediaDrugBankKEGG